drugset
drugset / Trial / NCT01908257

Lesinurad Interaction Study With Ranitidine

NCT01908257 ↗

Phase 1 Completed 16 enrolled Ardea Biosciences, Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

This is a drug-drug interaction study in healthy volunteers to evaluate the potential pharmacokinetic (PK) effects of ranitidine on lesinurad.

Timeline

Start
2013-07
Primary completion
2013-09
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lesinurad Small molecule 400 mg —
Subject Ranitidine Unknown 150 mg —

Indications

No indication recorded.